project id: TCGA-SARC; case submitter id: TCGA-HS-A5NA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; age at index: 65; days to birth: -24025; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; age at diagnosis: 24025; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 298.0; icd 10 code: C55; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Uterus, NOS; synchronous malignancy: No; tissue or organ of origin: Uterus, NOS; tumor grade: Not Reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 400.0; portion submitter id: TCGA-HS-A5NA-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 100.0;